1-5 of 5
Jeffrey S. Berger
Close
Sort by
Journal Articles

Myeloproliferative Neoplasms Are Associated with Increased Risk of Major Adverse Limb Events Among Patients Hospitalized for Peripheral Arterial Disease

Orly Leiva, Andrew M. Brunner, Joan How, Gabriela S. Hobbs, Jeffrey S Berger
Journal: Blood
Blood (2023) 142 (Supplement 1): 4570.
https://doi.org/10.1182/blood-2023-180783
Published: 2023
Journal Articles

Risk of Venous Thromboembolism Recurrence Among Rivaroxaban Treated Patients Who Continued Versus Discontinued Therapy: Analyses Among VTE Patients

Alok A. Khorana, MD, Jeffrey S Berger, MD, Philip S Wells, MD, Roger Seheult, MD, Veronica Ashton, MPH, François Laliberté, MA, Concetta Crivera, PharmD, MPH, Dominique Lejeune, MA, Jeff Schein, DrPH, MPH, Peter Wildgoose, PhD, Patrick Lefebvre, MA, Scott Kaatz, DO, MSc
Journal: Blood
Blood (2016) 128 (22): 144.
https://doi.org/10.1182/blood.V128.22.144.144
Published: 2016
Journal Articles

Ticagrelor Modulates Proliferation in Multiple Myeloma Via P1 and P2 Receptor-Mediated Mechanisms

Elan Meltzer, Aranzazu Mediero, Carl Whatling, Jeffrey S Berger, MD, Bruce Cronstein
Journal: Blood
Blood (2016) 128 (22): 5694.
https://doi.org/10.1182/blood.V128.22.5694.5694
Published: 2016
Journal Articles

Platelet WDR1 suppresses platelet activity and is associated with cardiovascular disease

Emilie Montenont, Christina Echagarruga, Nicole Allen, Elisa Araldi, Yajaira Suarez, Jeffrey S. Berger
Journal: Blood
Blood (2016) 128 (16): 2033–2042.
https://doi.org/10.1182/blood-2016-03-703157
Published: 2016
Includes: Supplemental data
Journal Articles

Reproducibility, Pre-Analytical Variables and Effect of Aspirin On Soluble P Selectin and CD40 Ligand.

Vanessa Valdes, BS, Michael A. Nardi, MS, Jeffrey S Berger, MD
Journal: Blood
Blood (2012) 120 (21): 2255.
https://doi.org/10.1182/blood.V120.21.2255.2255
Published: 2012